Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Bone Marrow Transplantation
|
September 1, 1994
Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission
N Vey, D Blaise, A M Stoppa, et al.
Bone Marrow Transplantation
|
March 1, 1988
Repeated courses of high dose melphalan and unpurged autologous bone marrow transplantation in children with acute non-lymphoblastic leukemia in first complete remission
G Michel, D Maraninchi, F Demeocq, et al.
The New England Journal of Medicine
|
May 21, 1998
Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia
G Dighiero, K Maloum, B Desablens, et al.
Bone Marrow Transplantation
|
January 1, 1990
Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission
D Blaise, M H Gaspard, A M Stoppa, et al.
Leukemia
|
June 9, 1999
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients
R Bouabdallah, A M Stoppa, J F Rossi, et al.
Oncology
|
August 10, 2005
Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma
E Chamorey, R Gressin, F Peyrade, et al.
Critical Reviews in Oncology/Hematology
|
February 10, 2015
Role of physical activity and sport in oncology: scientific commission of the National Federation Sport and Cancer CAMI
T Bouillet, X Bigard, C Brami, et al.
Leukemia
|
March 1, 1996
A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75
J Reiffers, F Huguet, A M Stoppa, et al.
Leukemia
|
July 30, 2011
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience
H Avet-Loiseau, M Roussel, L Campion, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Bone Marrow Transplantation
|
September 1, 1994
Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission
N Vey, D Blaise, A M Stoppa, et al.
Bone Marrow Transplantation
|
March 1, 1988
Repeated courses of high dose melphalan and unpurged autologous bone marrow transplantation in children with acute non-lymphoblastic leukemia in first complete remission
G Michel, D Maraninchi, F Demeocq, et al.
The New England Journal of Medicine
|
May 21, 1998
Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia
G Dighiero, K Maloum, B Desablens, et al.
Bone Marrow Transplantation
|
January 1, 1990
Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission
D Blaise, M H Gaspard, A M Stoppa, et al.
Leukemia
|
June 9, 1999
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients
R Bouabdallah, A M Stoppa, J F Rossi, et al.
Oncology
|
August 10, 2005
Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma
E Chamorey, R Gressin, F Peyrade, et al.
Critical Reviews in Oncology/Hematology
|
February 10, 2015
Role of physical activity and sport in oncology: scientific commission of the National Federation Sport and Cancer CAMI
T Bouillet, X Bigard, C Brami, et al.
Leukemia
|
March 1, 1996
A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75
J Reiffers, F Huguet, A M Stoppa, et al.
Leukemia
|
July 30, 2011
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience
H Avet-Loiseau, M Roussel, L Campion, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
Page
of 4